Coen van Guldener

3.7k total citations
56 papers, 2.6k citations indexed

About

Coen van Guldener is a scholar working on Rheumatology, Surgery and Clinical Biochemistry. According to data from OpenAlex, Coen van Guldener has authored 56 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 22 papers in Surgery and 13 papers in Clinical Biochemistry. Recurrent topics in Coen van Guldener's work include Folate and B Vitamins Research (26 papers), Esophageal and GI Pathology (15 papers) and Metabolism and Genetic Disorders (12 papers). Coen van Guldener is often cited by papers focused on Folate and B Vitamins Research (26 papers), Esophageal and GI Pathology (15 papers) and Metabolism and Genetic Disorders (12 papers). Coen van Guldener collaborates with scholars based in Netherlands, United States and Vietnam. Coen van Guldener's co-authors include Coen D.A. Stehouwer, Frank Stam, A. J. M. Donker, Piet M. ter Wee, Prabath W.B. Nanayakkara, M. J. F. M. Janssen, J Lambert, K. de Meer, Tamara van Gog and Kees van den Berge and has published in prestigious journals such as The Lancet, JAMA and Kidney International.

In The Last Decade

Coen van Guldener

56 papers receiving 2.5k citations

Peers

Countries citing papers authored by Coen van Guldener

Since Specialization

Citations

This map shows the geographic impact of Coen van Guldener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coen van Guldener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coen van Guldener more than expected).

Fields of papers citing papers by Coen van Guldener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coen van Guldener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coen van Guldener. The network helps show where Coen van Guldener may publish in the future.

Co-authorship network of co-authors of Coen van Guldener

This figure shows the co-authorship network connecting the top 25 collaborators of Coen van Guldener. A scholar is included among the top collaborators of Coen van Guldener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coen van Guldener. Coen van Guldener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients 2021 ·Research and Practice in Thrombosis and Haemostasis ·Milou A.M. Stals, Marco J.J.H. Grootenboers, Coen van Guldener, Fleur H.J. Kaptein, (unknown), Qingui Chen, (unknown), (unknown), Antonio Iglesias del Sol, Evert de Jonge, K.M. Kant, (unknown), (unknown), Suzanne C. Cannegieter, Frederikus A. Klok, Menno V. Huisman	44
2	Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease 2012 ·Clinical Nephrology ·(unknown), Prabath W.B. Nanayakkara, Frans J. van Ittersum, (unknown), Coen van Guldener, (unknown), Coen D.A. Stehouwer	8
3	Improving diagnosis of adult-type hypolactasia in patients with abdominal complaints 2011 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Brigitte C.M. Haberkorn, Anton A. M. Ermens, (unknown), Christa M. Cobbaert, Coen van Guldener	12
4	Randomized Placebo-Controlled Trial Assessing a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Plasma Asymmetric Dimethylarginine Concentration in Mild to Moderate CKD 2008 ·American Journal of Kidney Diseases ·Prabath W.B. Nanayakkara, Jessica C. Kiefte–de Jong, Piet M. ter Wee, Coen D.A. Stehouwer, Frans J. van Ittersum, Margreet R. Olthof, Tom Teerlink, Jos W. R. Twisk, Coen van Guldener, Yvo M. Smulders	31
5	Erectile dysfunction as the presenting symptom of a pheochromocytoma 2007 ·European Journal of Internal Medicine ·Koen Van Den Berge, Coen van Guldener, Peter van Wijngaarden	3
6	Non Invasive Treatment of Peri-aortic Inflammation after Endovascular Graft 2007 ·European Journal of Vascular and Endovascular Surgery ·(unknown), (unknown), Coen van Guldener, (unknown), Lijckle van der Laan	6
7	Homocysteine and the Kidney 2005 ·Current Drug Metabolism ·Coen van Guldener	22
8	Homocysteine and Methionine Metabolism in Renal Failure 2005 ·Seminars in Vascular Medicine ·Coen van Guldener, Coen D.A. Stehouwer	28
9	Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure 2005 ·Kidney International ·Prabath W.B. Nanayakkara, Tom Teerlink, Coen D.A. Stehouwer, (unknown), Annemieke M. W. Spijkerman, Casper G. Schalkwijk, Piet M. ter Wee, Coen van Guldener	86
10	Endothelial Dysfunction Contributes to Renal Function–Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency 2005 ·Journal of the American Society of Nephrology ·Frank Stam, Coen van Guldener, Annemarie Becker‐Commissaris, Joost Dekker, Robert J. Heine, L.M. Bouter, Coen D.A. Stehouwer	205
11	Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals 2005 ·Nephrology Dialysis Transplantation ·Frank Stam, Casper G. Schalkwijk, Coen van Guldener, Piet M. ter Wee, Coen D.A. Stehouwer	16
12	Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease 2004 ·Kidney International ·Frank Stam, Coen van Guldener, Piet M. ter Wee, Cornelis Jakobs, K. de Meer, Coen D.A. Stehouwer	21
13	Epidemiology of Homocysteine as a Risk Factor in Diabetes 2003 ·Metabolic Syndrome and Related Disorders ·(unknown), Yvo M. Smulders, Coen van Guldener, Coen D.A. Stehouwer	15
14	Homocysteine and blood pressure 2003 ·Current Hypertension Reports ·Coen van Guldener, Prabath W.B. Nanayakkara, Coen D.A. Stehouwer	89
15	Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients 2001 ·Kidney International ·(unknown), Muriël P.C. Grooteman, P. C. M. Bartels, Jacques van Limbeek, Coen van Guldener, Piet M. ter Wee, Menso J. Nubé	68
16	Hyperhomocysteinemia, Vascular Pathology, and Endothelial Dysfunction 2000 ·Seminars in Thrombosis and Hemostasis ·Coen van Guldener, Coen D.A. Stehouwer	122
17	Homocysteine and methionine metabolism in ESRD: A stable isotope study 1999 ·Kidney International ·Coen van Guldener, Wim Kulik, Ruud Berger, (unknown), Cornelis Jakobs, Dirk‐Jan Reijngoud, A. J. M. Donker, Coen D.A. Stehouwer, K. de Meer	128
18	Trochanter Osteomyelitis and Ipsilateral Arthritis due to Gemella morbillorum 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·M. van Dijk, Barend J. van Royen, P. Wuisman, T. A. M. Hekker, Coen van Guldener	10
19	No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients 1998 ·Nephrology Dialysis Transplantation ·Coen van Guldener, M. J. F. M. Janssen, J Lambert, Piet M. ter Wee, C. Jakobs, A. J. M. Donker, Coen D.A. Stehouwer	89
20	The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function 1998 ·The Netherlands Journal of Medicine ·Coen van Guldener	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact